PAXIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING PHASE 2 STUDY (PART 1) FOLLOWED BY AN OPEN-LABEL PERIOD (PART 2) TO ASSESS THE EFFICACY AND SAFETY OF PACRITINIB IN PATIENTS WITH VEXAS SYNDROME

Registry ID

PAC601

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

SOBI, INC

Start date

2025-12-11

Last update

2024-12-20

Conditions

• VEXAS SYNDROME

View on source registry